{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T15:59:31Z","timestamp":1791215971375,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1985,10,1]],"date-time":"1985-10-01T00:00:00Z","timestamp":496972800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[1985,10]]},"DOI":"10.1007\/bf00431813","type":"journal-article","created":{"date-parts":[[2004,11,11]],"date-time":"2004-11-11T04:19:20Z","timestamp":1100146760000},"page":"225-232","source":"Crossref","is-referenced-by-count":99,"title":["Diazepam-induced place preference conditioning: Appetitive and antiaversive properties"],"prefix":"10.1007","volume":"87","author":[{"given":"Christina","family":"Spyraki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kazandjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"Varonos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1016\/0006-2952(79)90549-5","volume":"28","author":"PR Andrews","year":"1979","unstructured":"Andrews PR, Johnston GAR (1979) GABA agonists and antagonists. Biochem Pharmacol 28:2697?2702","journal-title":"Biochem Pharmacol"},{"key":"CR2","first-page":"150","volume":"23","author":"P Bernard","year":"1981","unstructured":"Bernard P, Bergen K, Sobiski R, Robson RD (1981) CGS 8216 (2-phenyl-pyrazolo-(4,3-c) quinolin-3(5H)-one). An orally effective benzodiazepine antagonist. Pharmacologist 23:150","journal-title":"Pharmacologist"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/0024-3205(78)90614-8","volume":"22","author":"LM Billingsley","year":"1978","unstructured":"Billingsley LM, Kubena KR (1978) The effect of naloxone and picrotoxin on the sedative and anticonflict effects of benzodiazepines. Life Sci 22:897?906","journal-title":"Life Sci"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0091-3057(82)90006-5","volume":"16","author":"M Caudarella","year":"1982","unstructured":"Caudarella M, Campbell KA, Milgram NW (1982) Differential effects of diazepam (Valium) on brain stimulation reward sites. Pharmacol Biochem Behav 16:17?21","journal-title":"Pharmacol Biochem Behav"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/0024-3205(83)90108-X","volume":"32","author":"SJ Cooper","year":"1983","unstructured":"Cooper SJ (1983) Benzodiazepine-opiate antagonist interactions in relation to feeding and drinking behaviour (minireview) Life Sci 32:1043?1051","journal-title":"Life Sci"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.pa.19.040179.002531","volume":"19","author":"E Costa","year":"1979","unstructured":"Costa E, Guidotti A (1979) Molecular mechanisms in the receptor action of benzodiazepines. Ann Rev Pharmacol Toxicol 19:531?545","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0091-3057(81)90348-8","volume":"15","author":"Th Duka","year":"1981","unstructured":"Duka Th, Cumin R, Haefely W, Herz A (1981) Naloxone blocks the effect of diazepam and meprobamate on conflict behaviour in rats. Pharmacol Biochem Behav 15:115?117","journal-title":"Pharmacol Biochem Behav"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF00421923","volume":"26","author":"JD Findley","year":"1972","unstructured":"Findley JD, Robinson WW, Peregrino L (1972) Addiction to secobarbital and chlordiazepoxide in the rhesus monkey by means of a self-infusion preference procedure. Psychoparmacologia 26:91?114","journal-title":"Psychoparmacologia"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0091-3057(82)90237-4","volume":"16","author":"S Gerhardt","year":"1982","unstructured":"Gerhardt S, Prowse J, Liebman JM (1982) Anxiolytic drugs selectively increase preferred duration of rewarding brain stimulation in a shuttle box. Pharmacol Biochem Behav 16:795?799","journal-title":"Pharmacol Biochem Behav"},{"key":"CR10","volume-title":"Benzodiazepines, Monograph Series","author":"RR Griffiths","year":"1982","unstructured":"Griffiths RR, Ator NA (1982) Benzodiazepine self-administration in animals and humans: A comprehensive literature review. In: Benzodiazepines, Monograph Series, Health and Human Services Publication, U.S. Government Printing Office, Washington, DC"},{"key":"CR11","first-page":"649","volume":"215","author":"RR Griffiths","year":"1980","unstructured":"Griffiths RR, Bigelow GE, Liebson I, Kaliszak JE (1980) Drug preference in humans: Double-blind choice comparison of pentobarbital, diazepam and placebo. J Pharmacol Exp Ther 215:649?661","journal-title":"J Pharmacol Exp Ther"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00432169","volume":"75","author":"RR Griffiths","year":"1981","unstructured":"Griffiths RR, Lukas SE, Bradford LD, Brady JV, Snell JD (1981) Self-injection of barbiturates and benzodiazepines in Baboons. Psychopharmacology 75:101?108","journal-title":"Psychopharmacology"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/02791072.1983.10472119","volume":"15","author":"W Haefeley","year":"1983","unstructured":"Haefeley W (1983) The biological basis of benzodiazepine action. The benzodiazepines today-two decades of research and clinical experience. J Psychoact Drugs 15:19?39","journal-title":"J Psychoact Drugs"},{"key":"CR14","first-page":"137","volume-title":"The benzodiazepines-from molecular biology to clinical practice","author":"W Haefeley","year":"1983","unstructured":"Haefeley W, Bonetti EP, Burkard WP, Cumin R, Laurent JP, M\u00f6hler H, Pieri L, Pole P, Richards JG, Schaffner R, Scherschlicht R (1983) Benzodiazepine antagonists. In: Costa E (ed) The benzodiazepines-from molecular biology to clinical practice. Raven Press, New York pp 137?146"},{"key":"CR15","first-page":"130","volume-title":"Clinical and pharmacological aspects off sodium valproate (Epilim) in the treatment of epilepsy","author":"PKP Harvey","year":"1976","unstructured":"Harvey PKP (1976) Some aspects of the neurochemistry of Epilim. In: Legg NJ (ed) Clinical and pharmacological aspects off sodium valproate (Epilim) in the treatment of epilepsy. Turnbridge Wells: MCS Consultants pp 130?134"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0014-2999(83)90141-3","volume":"93","author":"T Haug","year":"1983","unstructured":"Haug T (1983) Neuropharmacological specificity of the diazepam stimulus complex: Effects of agonists and antagonists. Eur J Pharmacol 93:221?227","journal-title":"Eur J Pharmacol"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0014-2999(82)90058-9","volume":"80","author":"T Haug","year":"1982","unstructured":"Haug T, Gotestam KG (1982) The diazepam stimulus complex: Specificity in a rat model. Eur J Pharmacol 80:225?230","journal-title":"Eur J Pharmacol"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/0091-3057(83)90468-9","volume":"18","author":"ML Healey","year":"1983","unstructured":"Healey ML, Pickens RW (1983) Diazepam dose preference in humans. Pharmacol Biochem Behav 18:449?456","journal-title":"Pharmacol Biochem Behav"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/0091-3057(83)90338-6","volume":"19","author":"LJ Herberg","year":"1983","unstructured":"Herberg LJ, Williams SF (1983) Anti-conflict and depressant effects by GABA agonsits and antagonists, benzodiazepines and non-GABA-ergic anticonvulsants on self-stimulation and locomotor activity. Pharmacol Biochem Behav 19:625?633","journal-title":"Pharmacol Biochem Behav"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/978-1-4613-3967-0_7","volume-title":"Contemporary research in behavioral pharmacology","author":"CE Johanson","year":"1978","unstructured":"Johanson CE (1978) Drugs as reinforcers. In: Blackman DE, Sanger DJ (eds) Contemporary research in behavioral pharmacology Plenum Press, New York, pp 325?390"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/0014-2999(75)90125-9","volume":"30","author":"JO Johanson","year":"1975","unstructured":"Johanson JO, Jarbe TUC (1975) Diazepam as a discriminative cue: Its antagonism by bemegride. Eur J Pharmacol 30:372?375","journal-title":"Eur J Pharmacol"},{"key":"CR22","doi-asserted-by":"crossref","DOI":"10.1007\/978-94-011-6203-6","volume-title":"The Benzodiazepines","author":"J Marks","year":"1978","unstructured":"Marks J (1978) The Benzodiazepines. University Park, Baltimore"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000402410","volume":"17","author":"MJ Millan","year":"1981","unstructured":"Millan MJ, Duka Th (1981) Anxiolytic properties of opiates and endogenous opioid peptides and their relationship to the actions of benzodiazepines. Mod Probl Pharmacopsychiatry 17:123?141","journal-title":"Mod Probl Pharmacopsychiatry"},{"key":"CR24","first-page":"15","volume-title":"Anxiolytics: neurochemical, behavioural and clinical perspectives","author":"H M\u00f6hler","year":"1983","unstructured":"M\u00f6hler H, Richards JG (1983) Receptors for anxiolytic drugs. In: Malick JB, Enna SJ, Yamamura HI (eds) Anxiolytics: neurochemical, behavioural and clinical perspectives. Raven Press, New York, pp 15?40"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/BF00427782","volume":"82","author":"RF Mucha","year":"1984","unstructured":"Mucha RF, Iversen SD (1984) Reinforcing properties of morphine and naloxone revealed by conditioned place preerences: a procedural examination. Psychopharmacology 82:241?247","journal-title":"Psychopharmacology"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-8993(82)91123-4","volume":"243","author":"RF Mucha","year":"1982","unstructured":"Mucha RF, van der Kooy D, O'Shaugnessy M, Bucenieks P (1982) Drug reinforcement studied in rat using place conditioning. Brain Res 243:91?105","journal-title":"Brain Res"},{"key":"CR27","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/0024-3205(83)90293-X","volume":"33","author":"EB Nielsen","year":"1983","unstructured":"Nielsen EB, Valentine JD, Holohean AM, Appel JB (1983) Benzodiazepine receptor mediated discriminative cues: Effects of GABA-ergic drugs and inverse agonsits. Life Sci 33:2213?2220","journal-title":"Life Sci"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1037\/h0023471","volume":"62","author":"ME Olds","year":"1966","unstructured":"Olds ME (1966) Facilitatory action of diazepam and chlordiazepoxide on hypothalamic reward behaviour. J Comp Physiol Psychol 62:136?140","journal-title":"J Comp Physiol Psychol"},{"key":"CR29","first-page":"1","volume-title":"Anxiety: New research and changing concepts","author":"K Rickels","year":"1981","unstructured":"Rickels K (1981) Benzodiazepines: use and misuse. In: Klein DF, Rabkin JG (eds) Anxiety: New research and changing concepts. Raven Press, New York, pp 1?26"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/0024-3205(79)90403-X","volume":"25","author":"J Sawynok","year":"1979","unstructured":"Sawynok J, Pinsky C, LaBella FS (1979) Minireview on the specificity of naloxone as an opiate antagonist. Life Sci 25:1621?1632","journal-title":"Life Sci"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/0024-3205(84)90045-6","volume":"34","author":"EH Shannon","year":"1984","unstructured":"Shannon EH, Davis SL (1984) CGS 8216 noncompetitively antagonized the discriminative effects of diazepam in rats. Life Sci 34:2589?2596","journal-title":"Life Sci"},{"key":"CR32","first-page":"160","volume":"227","author":"EH Shannon","year":"1983","unstructured":"Shannon EH, Herling S (1983) Discriminative stimulus effects of diazepam in rats: evidence for a maximal effect. J Pharmacol Exp Ther 227:160?166","journal-title":"J Pharmacol Exp Ther"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/BF00428166","volume":"78","author":"GT Shearman","year":"1982","unstructured":"Shearman GT, Millan MJ, Herz A (1982) Lack of evidence for a role of endorphinergic mechanisms in mediating a discriminative stimulus produced by diazepam in rats. Psychopharmacology 78:282?284","journal-title":"Psychopharmacology"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3758\/BF03212315","volume":"11","author":"JE Sherman","year":"1983","unstructured":"Sherman JE, Hickis CF, Rice AG, Rusiniak KW, Garcia J (1983) Preferences and aversions for stimuli paired with ethanol in hungry rats. Anim Learn Behav 11:101?106","journal-title":"Anim Learn Behav"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0091-3057(80)90271-3","volume":"13","author":"JE Sherman","year":"1980","unstructured":"Sherman JE, Pickman C, Rice A, Liebeskind JC, Holman EW (1980a) Rewarding and aversie effects of morphine: Temporal and pharmacological properties. Pharmacol Biochem Behav 13:501?503","journal-title":"Pharmacol Biochem Behav"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0091-3057(80)90288-9","volume":"13","author":"JE Sherman","year":"1980","unstructured":"Sherman JE, Roberts T, Roskam SE, Holman EW (1980b) Temporal properties of rewarding and aversive effects of amphetamine in rats. Pharmacol Biochem Behav 13:597?599","journal-title":"Pharmacol Biochem Behav"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/BF00426529","volume":"69","author":"PA Soubri\u00e9","year":"1980","unstructured":"Soubri\u00e9 PA, Jobert A, Thi\u00e9bot MH (1980) Differential effects of naloxone against the diazepam-induced release of behavior in rats in three aversive situations. Psychopharmacology 69:101?105","journal-title":"Psychopharmacology"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(82)90685-0","volume":"253","author":"C Spyraki","year":"1982","unstructured":"Spyraki C, Fibiger HC, Phillips AG (1982a) Dopaminergic substrates of amphetamine-induced place preference conditioning. Brain Res 253:185?193","journal-title":"Brain Res"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-8993(82)90686-2","volume":"253","author":"C Spyraki","year":"1982","unstructured":"Spyraki C, Fibiger HC, Phillips AG (1982b) Cocaine-induced place preference conditioning: Lack of effects of neuroleptics and 6-hydroxydopamine lesions. Brain Res 253:195?203","journal-title":"Brain Res"},{"key":"CR40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF00432775","volume":"77","author":"C Spyraki","year":"1982","unstructured":"Spyraki C, Fibiger HC, Phillips AG (1982c) Attenuation by haloperidol of place preference conditioning using food reinforcement. Psychopharmacology 77:379?382","journal-title":"Psychopharmacology"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF00427827","volume":"79","author":"C Spyraki","year":"1983","unstructured":"Spyraki C, Fibiger HC, Phillips AG (1983) Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology 79:278?283","journal-title":"Psychopharmacology"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1001\/jama.1982.03320400059039","volume":"247","author":"RE Study","year":"1982","unstructured":"Study RE, Barker JL (1982) Cellular mechanisms of benzodiazepine action. JAMA 247:2147?2151","journal-title":"JAMA"},{"key":"CR43","first-page":"307","volume":"185","author":"T Yanagita","year":"1973","unstructured":"Yanagita T, Takahashi S (1973) Dependence liability of several sedative-hypnotic agents evaluated in monkeys. J Pharmacol Exp Ther 185:307?316","journal-title":"J Pharmacol Exp Ther"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1021\/jm00346a002","volume":"25","author":"N Yokoyama","year":"1982","unstructured":"Yokoyama N, Ritter B, Neubert AP (1982) 2-Arylpyrazolo (4,3-c) quinolin-3-ones. Novel. Agonist, partial agonist and antagonist of benzodiazepines. J Med Chem 25:337?339","journal-title":"J Med Chem"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1054-3589(08)60658-4","volume":"5","author":"G Zbinden","year":"1967","unstructured":"Zbinden G, Randall LO (1967) Pharmacology off benzodiazepines: Laboratory and Clinical Correlations. Adv Pharmacol 5:213?292","journal-title":"Adv Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00431813.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00431813\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00431813","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T22:39:45Z","timestamp":1554849585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00431813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,10]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,10]]}},"alternative-id":["BF00431813"],"URL":"https:\/\/doi.org\/10.1007\/bf00431813","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,10]]}}}